VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹65 Cr | ₹62 Cr | ₹50 Cr | ₹58 Cr | ₹45 Cr |
What is the latest Short Term Loans and Advances ratio of VENUS REMEDIES ?
Year | Short Term Loans and Advances |
---|---|
Mar2025 | ₹65 Cr |
Mar2024 | ₹62 Cr |
Mar2023 | ₹50 Cr |
Mar2022 | ₹58 Cr |
Mar2021 | ₹45 Cr |
How is Short Term Loans and Advances of VENUS REMEDIES Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2025 | ₹65 Cr | 5.81 | |
Mar2024 | ₹62 Cr | 24.08 | |
Mar2023 | ₹50 Cr | -14.58 | |
Mar2022 | ₹58 Cr | 30.09 | |
Mar2021 | ₹45 Cr | - |
Compare Short Term Loans and Advances of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹605.3 Cr | -0.3% | -7.6% | 29.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,370.0 Cr | 1% | -0.2% | -13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,087.0 Cr | -2.7% | -2.2% | 17.6% | Stock Analytics | |
CIPLA | ₹126,308.0 Cr | -1.7% | 4.1% | -5.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,614.0 Cr | 1% | 1.3% | 4.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,845.0 Cr | 2.5% | 7.7% | -6.7% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | -0.3% |
-7.6% |
29.4% |
SENSEX | 1.1% |
1% |
-0.9% |
You may also like the below Video Courses